This funded clinical trial will evaluate a novel anti-cancer agent
in a limited number of dogs with hemangiosarcoma. All dogs will
receive study drug; there is no placebo.

Trial Eligibility
Client-owned pet dogs with measurable hemangiosarcoma lesions (primary or metastatic); OR patients free of gross disease, having undergone splenectomy
within the past 28 days;

In addition, cases must meet the following criteria:
• Generally feeling well
• Prior treatment with chemotherapy acceptable with a required wash
out of 21 days
• Prior treatment with non-steroidal anti-inflammatory drugs (NSAID)
and prednisone acceptable with a required 14-day washout
• Prior treatment with radiation therapy is acceptable wtih a required
30-day washout
• No prior small molecule inhibitors (i.e. Palladia^TM )
• No prior immunotherapy (i.e. ONCEPT^TM melanoma vaccine)

Have a hemangiosarcoma case you think might qualify?
Please call Maria at 203-838-6626 or email maria@oncovet.com.
Remember our oncologists are always available for consultation on any oncology case!

For more information, please go to
animalci.com and click on “Trials”